Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
6.96 HKD | +2.50% | -2.66% | +4.19% |
04-15 | Ocumension Therapeutics Completes Phase III Trials for Postoperative Inflammation Drug | MT |
04-15 | Ocumension Therapeutics Announces Phase III Clinical Trial of OT-502 in China | CI |